Concord Healthcare Group Co., Ltd. (CONCORD HC GP, 02453) will ask shareholders to authorise a guarantee framework of up to RMB3.70 billion for its subsidiaries at an extraordinary general meeting (EGM) scheduled for 10 April 2026 in Beijing.

The proposed guarantees would cover a revolving 12-month period beginning on the date of shareholder approval and support various financing instruments—including working-capital loans, letters of credit, bank acceptance drafts, letters of guarantee, accounts-receivable financing, ultra-short-term commercial paper, project loans, acquisition loans and financial leasing. Specific credit terms, limits and interest rates will be finalised through separate agreements with individual financial institutions.

Management stated that the arrangement is intended to enhance overall financing efficiency and facilitate business development across the group’s operating subsidiaries. Because the guarantees relate solely to intra-group entities, the Board views associated risks as “manageable.” Ongoing monitoring of guaranteed balances and subsidiary performance has been pledged.

Shareholders will vote by poll on a single special resolution: 1) approval of the comprehensive credit-line application and guarantee provision for 2026, and 2) authorisation for the Board—or its delegates—to execute all related documentation within the approved cap.

Key timetable highlights: • H-share register closes 2-10 April 2026 (both days inclusive). • Transfers must be lodged by 16:30 on 1 April 2026 to qualify for EGM attendance. • Proxy forms are due no later than 09:30 on 9 April 2026.

The Board unanimously recommends voting in favour of the resolution. An announcement of poll results will be released after the meeting in accordance with Hong Kong Listing Rule 13.39(5).